BioPharmaTrend
Latest News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers

Anthony Platt

Partner and Co-Head of Technology at finnCap Cavendish    


Anthony has 17 years’ M&A experience and has worked on transactions with an aggregate value in excess of $5bn.

Prior to joining Cavendish, he spent seven years at Grant Thornton focused on UK mid-market technology transactions. Anthony trained in corporate finance at Ernst & Young in London and went on to lead several large global M&A processes in the technology sector, a sector in which he has led and originated deals for the last 12 years. Key areas of focus have been software, vertical applications, IT managed services, cyber security and telecoms.

Anthony started his career providing technology product support at Thomson Financial before spending time as a derivatives trader focused on European stock indices.

He has a BA honours degree in Business Studies and also holds the ICAEW Advanced Diploma in Corporate Finance.

Contributing Author

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Latest articles from Anthony


Navigating the UK Health Technology Market: Trends and Opportunities

Aug. 16, 2023      Business Intelligence
Navigating the UK Health Technology Market: Trends and Opportunities

The UK’s health technology market has seen unprecedented levels of M&A transactions and fundraising. The Covid-19 pandemic acted as a catalyst, accelerating the adoption of digital health solutions, and sparking interest amongst investors to get involved in the sector.

#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.